Abstract
Bacterial persisters are a subpopulation of cells that exhibit phenotypic resistance during exposure to a lethal dose of antibiotics. They are difficult to target and thought to contribute to the long treatment duration required for tuberculosis. Understanding the molecular and cellular biology of persisters is critical to finding new tuberculosis drugs that shorten treatment. This review focuses on mycobacterial persisters and describes the challenges they pose in tuberculosis therapy, their characteristics and formation, how persistence leads to resistance, and the current approaches being used to target persisters within mycobacterial drug discovery.
| Original language | English |
|---|---|
| Pages (from-to) | 492-499 |
| Number of pages | 8 |
| Journal | Microbiology (United Kingdom) |
| Volume | 165 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1 May 2019 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antibiotics
- Drug discovery
- Mycobacteria
- Non-replicating organisms
- Persistence
- Tuberculosis
Fingerprint
Dive into the research topics of 'The relevance of persisters in tuberculosis drug discovery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver